Are there any special Hib vaccination recommendations for American Indian/Alaska Native (AI/AN) children?

Hib meningitis incidence historically peaked at a younger age (4–6 months) among AI/AN infants than among other U.S. infant populations (6–7 months). ACIP has made a preferential recommendation for vaccination with a primary series of PedvaxHIB (PRP-OMP, Merck) or Vaxelis (DTaP-IPV-Hib-HepB, MSP Company) for AI/AN infants. PedvaxHIB and Vaxelis (which also contains PRP-OMP as its Hib component) both produce a protective antibody response after the first dose.